ADMA Biologics, Inc. (ADMA)
Biotechnology · Healthcare · $1.9B
Intrinsic Value (Consensus)
$13.93
Current Price
$8.33
Margin of Safety
+67.2%
67.2% Below Intrinsic Value
Value: $14
Price: $8
Valuation Model Estimates
Current Price: $8.33
DCF (Discounted Cash Flow)
$65.29
Graham Number
$5.60
Earnings Power Value
$7.49
Relative Value (P/E)
$20.36
Dividend Discount Model
Not applicable
—
Consensus Value
$13.93
Model Assumptions
Discount Rate
10.3%
Growth Rate
30.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
A
94
Profitability
25/25
Strength
25/25
Valuation
22/25
Growth
22/25
Financial Health Signals
Strong profitability — ROE of 31% (above 20% is excellent)
Low debt — conservative balance sheet
Strong earnings growth (30% YoY)
Key Financials
- EPS (TTM)
- $0.68
- EPS (Forward)
- $0.88
- Book Value
- $2.05
- P/E Ratio
- 20.0
- Forward P/E
- 19.6
- PEG Ratio
- —
- ROE
- 30.8%
- Debt/Equity
- 15%
- Revenue Growth
- 19.6%
- Earnings Growth
- 30.0%
- Dividend Yield
- N/A
- Beta
- 0.79
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-21
Source: Yahoo Finance